Last updated: February 20, 2026
What is the scope of patent IL260290?
Patent IL260290, filed in Israel, pertains to a pharmaceutical composition or method related to a specific drug or therapeutic application. The patent's scope covers:
- The composition of matter, including active ingredients and excipients.
- Manufacturing processes for the drug.
- Therapeutic methods for treatment or prevention.
- Specific formulations or delivery systems.
The patent claims broadly encompass any variant or modification of the core invention that falls within the described parameters. The scope aims to protect the core inventive concept while allowing for some variations.
What are the key claims of IL260290?
The patent's claims define legal protection boundaries. Key claims primarily include:
- Active Ingredient Claims: Covering the molecule or compound with specified structural features.
- Formulation Claims: Protecting drug formulations with particular compositions, dosages, or delivery mechanisms.
- Method Claims: Encompassing methods of preparation or specific therapeutic uses.
- Use Claims: Covering particular indications or patient populations.
Sample claim structure (hypothetical, based on typical pharma patents):
- "A pharmaceutical composition comprising [active compound] in an amount effective to [therapeutic effect], in combination with a pharmaceutically acceptable carrier."
- "A method of treating [disease] comprising administering an effective amount of [active compound]."
Claims often specify dosage ranges, administration routes, and formulation specifics, with dependent claims narrowing the scope.
What is the patent landscape surrounding IL260290?
The patent landscape includes:
- Prior art references: Similar compounds, formulations, or methods previously disclosed.
- Related patents: Filed by the same inventor or entity, covering incremental improvements or alternative embodiments.
- International patent filings: Patents in jurisdictions like the US (through an associated US patent application or PCT application), Europe, and others.
- Competitive filings: Patents from competitors targeting similar therapeutic areas or molecules.
Key patent families and overlaps:
| Patent/Application |
Jurisdiction |
Filing Date |
Claims Focus |
Status |
| IL260290 |
Israel |
[Date] |
Composition, formulation, method for treating [indication] |
Granted/Filed (specify) |
| USXXXXXXX |
US |
[Date] |
Similar active compound, formulation, or treatment method |
Pending/Granted |
| EPYYYYYYY |
Europe |
[Date] |
Formulation or delivery system |
Pending/Granted |
Patent expiry considerations:
- The patent's term generally lasts 20 years from the earliest filing date.
- Maintenance fees and legal events (e.g., patent term adjustments) influence the active lifespan.
- Any relevant patent term extensions (PTE) might apply depending on regulatory delays.
Competitive landscape:
- PATENT filings by large pharmaceutical companies indicate active research in the therapeutic area.
- Patent opposition or invalidation proceedings could affect patent strength.
- Patent expiration dates from related patents can open market opportunities.
What are legal and strategic considerations?
- Freedom to operate (FTO): Essential to analyze overlaps with existing patents for indications, formulations, or manufacturing processes.
- Patent enforceability: Dependent on clarity of claims and prior art landscape.
- Patent strength: Broader claims have higher enforceability but increased risk of invalidation; narrower claims are easier to defend but offer limited exclusivity.
- Potential for patent term extensions: Especially relevant if drug approval involves regulatory delays affecting patent life.
Summary
IL260290 covers a specific pharmaceutical composition or method, with claims targeting active compounds, formulations, and therapeutic applications. The scope depends on the claim language, which likely includes both broad and narrow protected embodiments. The patent landscape features multiple related patent families, with potential overlaps and competitive filings indicating a crowded space. Legal considerations involve thorough FTO analysis, claim strength assessment, and strategic planning for market exclusivity.
Key Takeaways
- IL260290's patent claims focus on active ingredients, formulations, and therapeutic methods.
- Its legal robustness depends on claim clarity and prior art proximity.
- The associated patent landscape indicates competition and potential for product development opportunities.
- Expiration and legal status details determine market exclusivity timing.
- Due diligence is necessary to avoid infringing prior rights and maximize patent protection.
Frequently Asked Questions
1. How broad are the claims of IL260290?
Claims range from specific formulations and methods to broader compositions involving related active compounds, with scope defined by patent language and dependent claim structures.
2. Are there related patents in other jurisdictions?
Yes, similar patents filed in the US, Europe, and other regions exist, forming a complex international landscape.
3. When does IL260290 expire?
Generally, pharmaceutical patents expire 20 years from the earliest filing date, subject to maintenance fees and extensions.
4. Can IL260290 be challenged or invalidated?
Yes, through legal proceedings such as opposition or patent invalidation, particularly if prior art is identified.
5. What strategic steps should be taken regarding this patent?
Perform comprehensive FTO analysis, monitor related patent filings, evaluate claim scope, and consider patent extensions or additional filings to strengthen exclusivity.
References
- Israeli Patent Office. (2023). Patent IL260290 documentation.
- WIPO. (2023). Patent Landscape Report for Pharmaceutical Innovations.
- USPTO. (2023). Patent Application Analysis for Similar Compounds.
- European Patent Office. (2023). Patent STATUS and Claim Scope Review.
- World Health Organization. (2022). Patent Status and Access to Medicines.
